Synthesis of furoannelated analogues of Emivirine (MKC-442)

Archiv der Pharmazie

Volumn 337, Issue 3, 2004, Pages 148-151

  Wamberg, Michael ^a   Pedersen, Erik B ^a   Nielsen, Claus ^b  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b STATENS SERUM INSTITUT   (Denmark)

Author keywords

Furoannelated Emivirine; HIV 1; Lead Tetraacetate Oxidative Ring Closure; Non nucleoside Reverse Transcriptase Inhibitors

Indexed keywords

1 BENZYLOXYMETHYL 7 PHENYL 5,7 DIHYDRO 1H FURO[3,4 D]PYRIMIDINE 2,4 DIONE; 1 ETHOXYMETHYL 7 PHENYL 1,5,6,7 TETRAHYDROCYCLOPENTA[D]PYRIMIDINE 2,4 DIONE; 1 ETHOXYMETHYL 7 PHENYL 5,7 DIHYDRO 1H FURO[3,4 D]PYRIMIDINE 2,4 DIONE; ALCOHOL DERIVATIVE; ANTIINFECTIVE AGENT; EMIVIRINE; UNCLASSIFIED DRUG; 6 BENZYL 1 (ETHOXYMETHYL) 5 ISOPROPYLURACIL; 6-BENZYL-1-(ETHOXYMETHYL)-5-ISOPROPYLURACIL; DRUG DERIVATIVE; RNA DIRECTED DNA POLYMERASE INHIBITOR; URACIL;

ARTICLE; CONFORMATION; DRUG SYNTHESIS; HUMAN IMMUNODEFICIENCY VIRUS 1; PRIORITY JOURNAL; RING CLOSING METATHESIS; SUBSTITUTION REACTION; CELL LINE; COMPARATIVE STUDY; DRUG EFFECT; STRUCTURE ACTIVITY RELATION; SYNTHESIS;

CELL LINE; HIV-1; REVERSE TRANSCRIPTASE INHIBITORS; STRUCTURE-ACTIVITY RELATIONSHIP; URACIL;

EID: 2642582499     PISSN: 03656233     EISSN: None     Source Type: Journal    
DOI: 10.1002/ardp.200300815     Document Type: Article

References (17)

1. M. Baba, H. Tanaka, E. De Clercq, R. Pauwels, J. Balzarini, D. Schols, H. Nakashima, C.-F. Perno, R. T. Walker, T. Miyasaka, Biochem. Biophys. Res. Commun. 1989, 165, 1375-1381.
2. T. Miyasaka, H. Tanaka, M. Baba, H. Hayakawa, R. T. Walker, J. Balzarini, E. De Clercq, J. Med. Chem. 1989, 32, 2507-2509.
3. S. Yuasa, Y. Sadakata, H. Takashima, K. Sekiya, N. Inouye, M. Ubasawa, M. Baba, Mol. Pharmacol. 1993, 44, 895-900.
4. M. Baba, S. Shigeta, S. Yuasa, H. Takashima, K. Sekiya, M. Ubasawa, H. Tanaka, T. Miyasaka, R. T. Walker, E. De Clercq, Antimicrob. Agents Chemother. 1994, 38, 688-692.
5. H. Tanaka, H. Takashima, M. Ubasawa, K. Sekiya, N. Inouye, M. Baba, S. Shigeta, R. T. Walker, E. De Clercq, T. Miyasaka, J. Med. Chem. 1995, 38, 2860-2865.
6. M. Baba, H. Tanaka, T. Miyasaka, S. Yuasa, M. Ubasawa, R. T. Walker, E. De Clercq, Nucleosides Nucleotides 1995, 14, 575-583.
7. G. M. Szczech, P. Furman, G. R. Painter, D.W. Barry, K. Borroto-Esoda, T. B. Grizzle, M. R. Blum, J.-P. Sommadossi, R. Endoh, T. Niwa, M. Yamamoto, C. Moxham, Antimicrob. Agents Chemother. 2000, 44, 123-130.
8. Triangle Pharmaceuticals Inc. Press release January 2002: http://www.tripharm.com
9. A. L. Hopkins, J. Ren, R. M. Esnouf, B. E. Willcox, E. Y. Jones, C. Ross, T. Miyasaka, R. T. Walker, H. Tanaka, D. K. Stammers, D. I. Stuart, J. Med. Chem. 1996, 39, 1589-1600.
10. J. S. Larsen, L. Christensen, G. Ludvig, P. T. Jørgensen, E. B. Pedersen, C. Nielsen, J. Soc. Chem., Perkin Trans. 1 2000, 3035-3038.
11. M. Lj. Mihailović, Z. Ceković, Z. Maksimović, D. Jeremić, Lj. Lorenc, R. I. Mamuzić, Tetrahedron 1956, 21, 2799-2812.
12. T. B. Johnson, J. C. Ambelang, J. Org. Chem. 1938, 60, 2941-2944.
13. L. Petersen, E. B. Pedersen, C. Nielsen, Synthesis 2001, 559-564.
14. K. Danel, E. Larsen, E. B. Pedersen, Synthesis 1995, 934-936.
15. T. Mosmann, J. Immunol. Methods 1983, 65, 55-63.
16. S. Harada, Y. Koyanagi, N. Yamamoto, Science 1985, 229, 563-566.
17. M. Popovic, M. G. Sarngadharan, E. Read, R. C. Gallo, Science 1984, 224, 497-500.